Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹19 Cr
Revenue (TTM)
₹3 Cr
Net Profit (TTM)
₹0 Cr
ROE
1.1 %
ROCE
1.8 %
P/E Ratio
230.4
P/B Ratio
1.7
Industry P/E
69.6
EV/EBITDA
56.4
Div. Yield
0 %
Debt to Equity
0.1
Book Value
₹15.9
EPS
₹0.2
Face value
10
Shares outstanding
6,052,170
CFO
₹-8.05 Cr
EBITDA
₹-1.53 Cr
Net Profit
₹0.14 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Novateor Research
| 30.0 | 30.0 | -- | -23.4 | 10.9 | 44.3 | -- |
|
BSE FMCG*
| -13.9 | -9.7 | -13.2 | -8.8 | 2.5 | 7.2 | 8.6 |
|
Company
|
2025
|
2024
|
2021
|
2020
|
|---|---|---|---|---|
|
Novateor Research
| -43.6 | 22.4 | 90.3 | -76.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 62.8 | 32.1 |
|
BSE FMCG
| -2.1 | 1.5 | 9.3 | 10.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Novateor Research
|
34.5 | 18.9 | 2.8 | 0.1 | -- | 1.1 | 230.4 | 1.7 |
| 106.8 | 102.1 | 1.4 | -3.3 | -87.6 | -2.8 | -- | 3.3 | |
| 1,919.3 | 52,211.7 | 5,902.2 | 1,327.0 | 29.0 | 82.1 | 39.3 | 27.4 | |
| 78.8 | 10,595.9 | 299.2 | 83.5 | 30.9 | 23.1 | 126.9 | 20.3 | |
| 7,912.0 | 25,807.5 | 3,075.0 | 620.5 | 26.3 | 56.8 | 41.6 | 19.3 | |
| 281.8 | 8,934.7 | 2,268.4 | 155.8 | 6.2 | 13 | 57.4 | 6.8 | |
| 8.0 | 71.0 | 94.2 | -5.3 | -9.3 | -1.8 | -- | 0.4 | |
| 215.0 | 13.4 | 5.8 | -0.2 | -23.6 | -- | -- | -7.5 | |
| 145.0 | 99.5 | 25.0 | 5.3 | -- | 68 | 19 | 2.9 | |
| 391.0 | 692.2 | 278.6 | 12.8 | 5.4 | 8.7 | 52.8 | 4.1 |
No Review & Analysis are available.
Manufacture of basic chemicals
Incorporated
2011
Chairman
--
Managing Director
Navdeep Subhashbhai Mehta
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Novateor Research Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Novateor Research Laboratories Ltd is ₹31.21 (BSE) as of 03-Feb-2026 IST. Novateor Research Laboratories Ltd has given a return of 10.87% in the last 3 years.
The P/E ratio of Novateor Research Laboratories Ltd is 230.35 times as on 03-Feb-2026, a 231 premium to its peers’ median range of 69.60 times.
The P/B ratio of Novateor Research Laboratories Ltd is 1.70 times as on 03-Feb-2026, a 69 discount to its peers’ median range of 5.51 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
212.12
|
2.26
|
|
2024
|
0.00
|
0.00
|
|
2023
|
244.06
|
1.19
|
|
2022
|
0.00
|
0.55
|
|
2021
|
256.42
|
0.40
|
The 52-week high and low of Novateor Research Laboratories Ltd are Rs 57.50 and Rs 20.08 as of 19-Mar-2026.
Novateor Research Laboratories Ltd has a market capitalisation of ₹ 19 Cr as on 03-Feb-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Novateor Research Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.64
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.